InvestSMART

Noxopharm Limited (ASX: NOX) - Announcements

Current share price for NOX : $0.083 0.001 (1.22%)+

ASX company news and announcements for Noxopharm Limited (NOX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Noxopharm Limited (NOX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Noxopharm Limited (NOX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Noxopharm Limited (NOX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$26 Appendix 2A 31 May 2021 3:34PM $0.680 $0.083 fallen by 87.79%
$26 Appendix 3G 31 May 2021 3:31PM $0.680 $0.083 fallen by 87.79%
$26 Noxopharm Extraordinary General Meeting Results 31 May 2021 11:13AM $0.640 $0.083 fallen by 87.03%
$26 New Independent Trial Data Supports Potential of Veyonda 31 May 2021 8:32AM $0.600 $0.083 fallen by 86.17%
$26 Noxopharm to Present to Share Cafe Hidden Gems Webinar 13 May 2021 9:52AM $0.520 $0.083 fallen by 84.04%
$26 NOXCOVID Trial Achieves Full Enrolment 12 May 2021 8:43AM $0.565 $0.083 fallen by 85.31%
$26 Cleansing Notice 7 May 2021 2:59PM $0.580 $0.083 fallen by 85.69%
$26 Appendix 2A 7 May 2021 2:58PM $0.580 $0.083 fallen by 85.69%
$26 Veyonda FDA Approved Trial to Commence 7 May 2021 8:59AM $0.485 $0.083 fallen by 82.89%
$26 Securities Trading Policy 4 May 2021 2:46PM $0.560 $0.083 fallen by 85.18%
$26 Cleansing Notice 30 Apr 2021 2:50PM $0.600 $0.083 fallen by 86.17%
$26 Appendix 2A 30 Apr 2021 2:49PM $0.600 $0.083 fallen by 86.17%
$26 Change of Director's Interest Notice - BP 30 Apr 2021 2:46PM $0.600 $0.083 fallen by 86.17%
$26 Lapsing of Unlisted Options 30 Apr 2021 2:45PM $0.600 $0.083 fallen by 86.17%
$26 Publications Positive Review of Veyonda in Chemotherapy 30 Apr 2021 8:50AM $0.600 $0.083 fallen by 86.17%
$26 Notice of General Meeting/Proxy Form 29 Apr 2021 8:15AM $0.555 $0.083 fallen by 85.05%
$26 March Quarterly Activities Report and Appendix 4C 27 Apr 2021 9:04AM $0.630 $0.083 fallen by 86.83%
$26 Veyonda Showing Potential to Prevent Cytokine Storm 22 Apr 2021 11:51AM $0.630 $0.083 fallen by 86.83%
$26 Pause in Trading 22 Apr 2021 9:58AM $0.630 $0.083 fallen by 86.83%
$26 Cleansing Notice 12 Apr 2021 9:00AM $0.695 $0.083 fallen by 88.06%
$26 Appendix 2A 12 Apr 2021 8:59AM $0.695 $0.083 fallen by 88.06%
$26 Veyonda Patent Lodged for Major Septic Shock Opportunity 6 Apr 2021 8:32AM $0.630 $0.083 fallen by 86.83%
$26 Corporate Presentation for Switzer Virtual Investor Day 29 Mar 2021 10:01AM $0.640 $0.083 fallen by 87.03%
$26 Noxopharm IONIC Immuno-Oncology Trial Commences 19 Mar 2021 8:45AM $0.685 $0.083 fallen by 87.88%
$26 ASX Small-Mid Cap Conference Corporate Presentation 16 Mar 2021 9:21AM $0.670 $0.083 fallen by 87.61%

251 - 275 of 794 results

Page 11 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.